Adeno-Associated Virus Gene Therapy: Translational Progress and Future Prospects in the Treatment of Heart Failure

Despite advances in treatment over the past decade, heart failure remains a significant public health burden and a leading cause of death in the developed world. Gene therapy provides a promising approach for preventing and reversing cardiac abnormalities, however, clinical application has shown limited success to date. A substantial effort is being invested into the development of recombinant adeno-associated viruses (AAVs) for cardiac gene therapy as AAV gene therapy offers a high safety profile and provides sustained and efficient transgene expression following a once-off administration.

Source: Heart, Lung and Circulation - March 17, 2018 Category: Cardiology Authors: Sebastian Bass-Stringer, Bianca C. Bernardo, Clive N. May, Colleen J. Thomas, Kate L. Weeks, Julie R. McMullen Tags: Review Source Type: research